OHSU was about to enroll patients in Covid-19 trial suddenly paused by drugmaker
October 13, 2020
Akram Khan, M.D., is lead OHSU researcher for a clinical trial involving synthetic antibodies called ACTIV-3; the study was actively recruiting patients when it was paused Oct. 13.